Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Survey finds just 40 percent of adults 'absolutely certain' they will get H1N1 vaccine

Survey finds just 40 percent of adults 'absolutely certain' they will get H1N1 vaccine

October 05, 2009

Major reasons people saying 'no' or 'maybe' to vaccine include belief they are at low risk of illness and concerns about vaccine safety

Boston, MA-In a new survey, Harvard School of Public Health (HSPH) researchers found that just 40% of adults are "absolutely certain" they will get the H1N1 vaccine for themselves, and 51% of parents are "absolutely certain" that they will get the vaccine for their children. The survey examined the reasoning among those who said they would not get the vaccine or might not. This is the latest in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program at HSPH. The polling was done September 14-20, 2009.




Public Mixed on Getting Vaccine, but Interest May Jump If Outbreak Is Severe

About six in ten adults are not "absolutely certain" they will get the H1N1 vaccine for themselves, including 41% who say they will not get it, 6% who say they don't know if they will get it, and 11% who say they are planning to get it but may change their mind. About four in ten parents (44%) are not "absolutely certain" that they will get the vaccine for their children, including 21% who will not get it, 7% who don't know, and 16% who say they are planning to get it but may change their mind.

If there were people in their community who were sick or dying from H1N1, roughly six in ten adults (59%) who say they do not think they'll get the vaccine would change their mind and get it for themselves. About the same percentage of parents (60%) who say they do not think they'll get the vaccine for their children would change their minds if H1N1 was causing sickness or death in their community.

"These findings suggest that public health officials need to be prepared for a surge in demand for the H1N1 vaccine if the H1N1 flu becomes more severe," said Robert J. Blendon, Professor of Health Policy and Political Analysis at HSPH.

Major Reasons for Not Getting Vaccine or Being Unsure

Those who were not "absolutely certain" they will get the H1N1 vaccine cited the following as the top "major" reasons for their thinking: (1) they are concerned about getting side effects from the vaccine (30%); (2) they don't think they are at risk of getting a serious case of the illness (28%); and (3) they think they could get medication to treat H1N1 if they do get sick (26%). The top "major" reasons cited by parents who are not "absolutely sure" they will get the vaccine are that (1) they are concerned about side effects of the vaccine (38%); (2) they are concerned that their children could get other illnesses from the vaccine (33%); and (3) they do not trust public health officials to provide correct information about the safety of the vaccine (31%).

"There's still a lot of uncertainty about what people will ultimately do in terms of getting the vaccine. If public health officials want to encourage a larger number of people to get vaccinated this fall, they will need to address the public's concerns in the coming weeks," said Blendon.

Safety Concerns

At this point in time, only about a third (33%) of the public sees the H1N1 vaccine as very safe "generally for most people to take." By comparison, the figure is 57% for the seasonal flu vaccine. A smaller fraction of the public thinks the H1N1 vaccine is very safe for particular groups to take, including children ages 6 months to 2 years (18%) and pregnant women (13%). The Centers for Disease Control is encouraging these groups, among others, to get the vaccine as early as possible.

Concerns About Outbreak on the Rise

Public concern about a fall or winter outbreak of H1N1 has risen since June. Roughly three-quarters of the public (76%) believe there will be widespread cases of H1N1 this fall or winter with people getting very sick, which is an increase from June when only 59% felt the same way. More people are also now concerned that they or someone in their immediate family will get sick from H1N1 during the next 12 months (52% in later September, as compared to 38% in June). Roughly two-thirds of people (64%) think that public health officials' concerns about a possible outbreak have been justified, while one third (31%) think that they have been overblown.

This poll is part of a series of polls about the way that Americans and their institutions are responding to the H1N1 flu outbreak. The first three focus on the American public, and the fourth focuses on views of businesses across the United States.

Methodology

This poll is part of an on-going series of surveys focused on the public and biological security by the Harvard Opinion Research Program (HORP) at Harvard School of Public Health. The study was designed and analyzed by researchers at the Harvard School of Public Health (HSPH). The project director is Robert J. Blendon of the Harvard School of Public Health. The research team also includes Gillian K. SteelFisher, John M. Benson, and Kathleen J. Weldon of the Harvard School of Public Health, and Melissa J. Herrmann of SSRS/ICR. Fieldwork was conducted via telephone (including both landline and cell phone) for HORP by SSRS/ICR of Media (PA) September 14-20, 2009.

The survey was conducted with a representative national sample of 1,042 adults age 18 and over, including oversamples of non-Hispanic African Americans and Hispanics. Altogether, 144 non-Hispanic African Americans and 126 Hispanics were interviewed. In the overall results, these groups were weighted to their actual proportion of the total adult population.

The margin of error for the total sample is plus or minus 3.7 percentage points. Possible sources of non-sampling error include non-response bias, as well as question wording and ordering effects. Non-response in telephone surveys produces some known biases in survey-derived estimates because participation tends to vary for different subgroups of the population. To compensate for these known biases, sample data are weighted to the most recent Census data available from the Current Population Survey for gender, age, race, education, region, and number of adults in the household. Other techniques, including random-digit dialing, replicate subsamples, and systematic respondent selection within households, are used to ensure that the sample is representative.

Harvard School of Public Health



Related H1N1 Vaccine Current Events and H1N1 Vaccine News Articles H1N1 Vaccine Current Events and H1N1 Vaccine News RSS H1N1 Vaccine Current Events and H1N1 Vaccine News RSS
Poll: Many parents, high-priority adults who tried to get H1N1 vaccine unable to get it
A new national poll from Harvard School of Public Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so.

Lessons from flu seasons past
Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.

NIH prepares to launch 2009 H1N1 influenza vaccine trial in people with asthma
The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease.

Most would refuse emergency use H1N1 vaccine or additive
A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study.

Medical ethics experts identify, address key issues in H1N1 pandemic
The anticipated onset of a second wave of the H1N1 influenza pandemic could present a host of thorny medical ethics issues best considered well in advance, according to the University of Toronto Joint Centre for Bioethics, which today released nine papers for public discussion.

Rice researchers seek better vaccine procedure
As manufacturers work furiously to make a vaccine to protect against 2009 influenza A (H1N1) virus, a Rice University bioengineer is trying to improve the process for future flu seasons. The goal is to shorten the time it takes to identify targeted flu strains and manufacture the vaccines for them.

NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates
Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines.
More H1N1 Vaccine Current Events and H1N1 Vaccine News Articles
Sovereign Silver 2 oz Fine Mist Spray

Sovereign Silver 2 oz Fine Mist Spray
by Natural Immunogenics

Benefits of Sovereign Silver Bio-Active Silver Hydrosol- To support your immune system for all of its needs, choose Sovereign Silver Bio Active Hydrosol the #1 Selling silver supplement in America.* It has a unique combination of five benefits no other manufacturer can match: 1. Actively Charged (Bio-Active) 2. Easily Absorbed 3. Less Is More 4. Perfectly Safe. 5. 99.999% PURE

60 Minutes - H1N1 (November 1, 2009)

60 Minutes - H1N1 (November 1, 2009)

Airdate 11/01/09  Where is the vaccine that was supposed to save the nation from the H1N1 virus? Almost 100 people have died from the virus, hospitalizations are on the rise, but the vaccine is still in short supply. Health and Human Services Secretary Kathleen Sebelius tells Scott Pelley that it won't be long before everyone who wants the vaccine will get the vaccine, and she says it is safe and effective.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

  Pandemic influenza A (H1N1) vaccines, antivirals.(DRUGS, PREGNANCY, AND LACTATION): An article from: OB GYN News
by Christina Chambers (Author)

This digital document is an article from OB GYN News, published by International Medical News Group on October 1, 2009. The length of the article is 812 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Pandemic influenza A (H1N1) vaccines, antivirals.(DRUGS, PREGNANCY, AND LACTATION)
Author: Christina Chambers
Publication: OB GYN News (Magazine/Journal)
Date: October 1, 2009
Publisher: International Medical News Group
Volume: 44 Issue: 12 Page: 20(1)

Distributed by Gale, a part of Cengage...

40 Count Box of N95 Niosh Rated Respirators CDC Recommended for H1N1 Swine Flu Masks

40 Count Box of N95 Niosh Rated Respirators CDC Recommended for H1N1 Swine Flu Masks
by MCS Online

Keep yourself safe with this kit of 40 N95 Rated Niosh Respirators!

Warning Swine Flu Test Subject Keep Back Sign Logo Men's Tee Short Sleeve Size XL White

Warning Swine Flu Test Subject Keep Back Sign Logo Men's Tee Short Sleeve Size XL White
by 99 Volts



  ACIP picks five groups for novel H1N1 vaccine; children are one of the priority groups.(INFECTIOUS DISEASE): An article from: Pediatric News
by Miriam E. Tucker (Author)

This digital document is an article from Pediatric News, published by International Medical News Group on August 1, 2009. The length of the article is 790 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: ACIP picks five groups for novel H1N1 vaccine; children are one of the priority groups.(INFECTIOUS DISEASE)
Author: Miriam E. Tucker
Publication: Pediatric News (Magazine/Journal)
Date: August 1, 2009
Publisher: International Medical News Group
Volume: 43 Issue: 8 Page: 1(2)

Distributed by Gale, a part of Cengage...

60 Minutes - H1N1 (October 18, 2009)

60 Minutes - H1N1 (October 18, 2009)

Airdate 10/18/09  The H1N1 virus is already setting infection records in this country, and while most people who get this flu can handle it, in some cases, H1N1 can be deadly. Scott Pelley follows the case of 15-year-old Luke Duvall, a high school athlete in intensive care in Little Rock, Arkansas. With staphylococcal pneumonia on top of the H1N1, Luke is on a respirator and fighting for his life.

This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.

Individual H1N1 Swine Flu Kit Recommended by CDC for Prevention

Individual H1N1 Swine Flu Kit Recommended by CDC for Prevention
by MCS Online

Keep yourself safe this year with the cheapest kit on the market. Kit contains: 1 N95 Niosh Rated Respirator, 1 Bottle of 2 oz Purell, 10 Purell Deep Hand Sanitizing Wipes, 1 Pair of Nitrile Medical Grade Protective Gloves.

  H1N1 vaccine will be available early this month.(NEWS): An article from: Skin & Allergy News
by Mitchel L. Zoler (Author)

This digital document is an article from Skin & Allergy News, published by International Medical News Group on October 1, 2009. The length of the article is 608 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: H1N1 vaccine will be available early this month.(NEWS)
Author: Mitchel L. Zoler
Publication: Skin & Allergy News (Magazine/Journal)
Date: October 1, 2009
Publisher: International Medical News Group
Volume: 40 Issue: 10 Page: 4(1)

Distributed by Gale, a part of Cengage...

Warning Bird Flu Test Subject Men's Hoodie Sweat Shirt White XXL

Warning Bird Flu Test Subject Men's Hoodie Sweat Shirt White XXL
by 99 Volts



© 2009 BrightSurf.com